pretickt

CI financials

Cigna Corporation · end-of-day data as of Oct 16, 2026

Cigna Corporation
CI · $79.88B
$302.30+5.0%last 60 sessions · close Oct 16, 2026
$238.99$302.8252 weeks
Buy · 24 analystsPT $335.33 +10.9%
  • P/E vs own+4.6%
  • P/E vs sector-55.6%
  • Target upside+10.9%
  • Off 52w high-0.2%
  • Insiders-$6.29M
  • FCF yield+11.4%
  • Earnings in20d
  • Trendbearish
  • Sector▲ +16.0%
  • RSI73
  • MA20×50↑ in ~4d
  • Volume0.9x
  • Support-2.6%
  • Resistance+0.7%

CI reported revenue of $71.67B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 6.6% from a year earlier. It posted diluted EPS of $6.29, free cash flow of -$718M and a net margin of 2.3%.

Valuation

  • P/E12.5x
  • P/E vs own+4.6%
  • P/E vs sector-55.6%
  • FCF yield+11.4%
  • Market cap$79.88B

Quarterly results

Q2 FY2026: Revenue +6.6% year over year, free cash flow -1.0% of revenue, operating margin 3.7%.

RevenueFree cash flow
Q3 FY2023Q4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Q2 FY2026Jun 30, 2026$71.67B6.29-$718M20.9%3.7%2.3%
Q1 FY2026Mar 31, 2026$68.49B6.26$864M9.4%3.4%2.4%
Q4 FY2025Dec 31, 2025$72.47B4.64$5.83B7.7%3.0%1.7%
Q3 FY2025Sep 30, 2025$69.75B6.97$3.14B8.5%3.7%2.7%
Q2 FY2025Jun 30, 2025$67.23B5.71-$2.17B11.7%3.6%2.3%
Q1 FY2025Mar 31, 2025$65.5B4.85$1.59B10.1%3.0%2.0%
Q4 FY2024Dec 31, 2024$65.65B5.13$4.88B9.8%3.3%2.2%
Q3 FY2024Sep 30, 2024$63.69B2.63-$353M10.4%4.0%1.2%
Q2 FY2024Jun 30, 2024$60.52B5.45-$105M10.8%4.0%2.6%
Q1 FY2024Mar 31, 2024$57.26B-0.97$4.54B11.2%3.9%-0.5%
Q4 FY2023Dec 31, 2023$51.11B3.49$1.1B12.9%4.0%2.0%
Q3 FY2023Sep 30, 2023$49.05B4.74$2.42B13.2%4.6%2.9%